Jordi Sevilla

Jordi Sevilla

Auto-generated profile, based on publicly available information

Jordi Sevilla

Institut Pasteur

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MÁMiguel Álvarez-Herrera
Miguel Álvarez-Herrera
JSJordi Sevilla
Jordi Sevilla
PRPaula Ruiz-Rodriguez
Paula Ruiz-Rodriguez
AVAndrea Vergara
Andrea Vergara
Jordi VilaJordi Vila
Jordi Vila
MCMireia Coscollá
Mireia Coscollá
Viral mutations within patients nurture the adaptive potential of SARS-CoV-2 during chronic infections, which are a potential source of variants of concern. However, there is no integrated framework for the evolutionary analysis of intra-patient SARS-CoV-2 serial samples. Herein we describe VIPERA (Viral Intra-Patient Evolution Reporting and Analysis), a new software that integrates the evaluation of the intra-patient ancestry of SARS-CoV-2 sequences with the analysis of evolutionary trajectories of serial sequences from the same viral infection. We have validated it using positive and negative control datasets and have successfully applied it to a new case, thus enabling an easy and automatic analysis of intra-patient SARS-CoV-2 sequences.

17 August 2026 in medRxiv
Verified
Preprint
Open access
JSJordi Sevilla
Jordi Sevilla
JKJulia Kende
Julia Kende
SDSebastián Duchêne
Sebastián Duchêne
MMMichael T Meehan
Michael T Meehan
Bacterial sexually transmitted infections (STIs) pose a major global public health challenge, with Neisseria gonorrhoeae being of particular concern due to its persistently high prevalence and increasing antimicrobial resistance. The emergence of multidrug-resistant strains has narrowed treatment options, highlighting the importance of prevention. In this context, knowing whether there is superspreading (transmission heterogeneity) within a population becomes crucial for accurate public health measures. However, classic methods to quantify superspreading rely on dense contact tracing, and this is not always feasible. As an alternative, we can use Bayesian phylodynamic modelling to infer transmission dynamics, including superspreading. Yet modelling transmission dynamics using bacterial data remains problematic, although it is widely used for viral data. Here, we apply a multi-type birth-death model parametrised to quantify superspreading in N. gonorrhoeae outbreaks, estimating the fraction and relative impact of superspreaders and reproductive numbers for superspreaders and non-superspreaders. We also use a hierarchical modelling strategy with partial pooling to increase the power for detecting superspreading in each cluster. Model performance was successfully evaluated across a range of superspreading scenarios using both transmission-informed phylogenies and sequence data with phylogenetic uncertainty. Application to empirical genomic data revealed a substantial role of superspreading in N. gonorrhoeae transmission during the COVID-19 pandemic in Australia. These results highlight the impact of superspreading in N. gonorrhoeae transmission and the importance of detecting it to efficiently stop the dissemination of the disease